MedTrace Logo

Effect of Alpha Tocopherol and Psyllium on Lipid Levels in Dyslipidaemia Patients

NCT07610304 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-27

No results posted yet for this study

Summary

The goal of this clinical trial is to find out whether Vitamin E (Alpha tocopherol), taken alone or together with Psyllium husk (a type of dietary fibre), can improve blood fat levels in adults with dyslipidaemia (abnormal blood levels of two types of fat: cholesterol and triglycerides).

The main questions this study aims to answer are:

* Does Vitamin E (400 mg/day) alone help lower blood cholesterol and triglyceride levels?
* Does combining Vitamin E (400 mg/day) with Psyllium husk (10 g/day) lead to better results compared to participants taking Vitamin E alone? Researchers will compare all three groups i.e. Group A taking Vitamin E alone, Group B taking Vitamin E and Psyllium husk and Group C receiving a placebo (a look alike supplement).

The hypothesis of the study is that 'There is a noticeable difference between all the three study groups.'

Participants will:

* Take their assigned (specific to the concerned group under study) treatment daily for 60 days.
* Visit study place every two weeks for follow-up.
* Have blood tests done at the beginning and end of the study to check for changes in cholesterol and triglyceride levels.

Conditions

  • Dyslipidaemia

Interventions

DIETARY_SUPPLEMENT

Alpha tocopherol

400 mg Alpha Tocopherol supplement to be taken daily for a duration of 60 days

COMBINATION_PRODUCT

Combination therapy (Alpha Tocopherol and Psyllium husk)

400 mg Alpha Tocopherol taken along with 10 g psyllium daily for duration of 60 days

OTHER

Placebo Control

A placebo similar to Vitamin E supplement taken daily for 60 days

Sponsors & Collaborators

  • NUR International University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-15
Primary Completion
2022-08-15
Completion
2022-08-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07610304 on ClinicalTrials.gov